Abstract:Objective To study the effect of microRNA-218 (miR-218) on the invasion of cholangiocarcinoma cells by Survivin.Methods Two cholangiocarcinoma cell lines (CCLP1) and (QBC939) were cultured,and transfected with miR-218 mimicss.Negative control group and blank control group were set up.The invasiveness was determined via BD Martigel basement membrane matrix gel invasion Chamber.3 results were randomly selected from each group.The CCLP1 and QBC939 cells were co transfected with miR-218 mimic and pMIR-Survivin,miR-218 mimic and pMIR-Survivin-mut,respectively.3 results were randomly selected from each group,and the luciferase activity was detected by enzyme labelling instrument,and the correlation between miR-218 and Survivin was discussed.Results The numbers of CCLP1 cells transfected with miR-218,cells in negative control group,and cells in NC group were (28.33 ±4.16),(72.00 ± 8.72) and (74.33 ±4.04) cells,respectively;The numbers of QBC939 cells transfected with miR-218,cells in negative control group,and cells in NC group were (7.33 ± 2.08),(22.00 ± 4.36) and (22.00 ± 4.00) cells,respectively.Results showed that transfection of miR-218 mimics can inhibit the invasion ability of cholangiocarcinoma (The P values of CCLP1 cell line and QBC939 cell line were 0.000,0.004).Luciferase activity detection results showed that luciferase activity in QBC939 wild type miRNA-218 group was 1.489 ±0.079,luciferase activity in negative control group was 2.825 ±0.068,luciferase activity in NC group was 2.747 ±0.081,luciferase activity in QBC939 mutant miRNA-218 group was 3.078 ± 0.138,luciferase activity in negative control group was 2.944 ±0.144,the luciferase activity of the NC group was 2.807 ± 0.090,the luciferase activity of the CCLP1 wild type miRNA-218 group was 1.322 ±0.039,the luciferase activity of the negative control group was 2.362 ± 0.129,the luciferase activity of the NC group was 2.368 ± 0.154,the luciferase activity of the CCLP1 mutant miRNA-218 group was 2.202 ± 0.073,and the negative control group luciferase activity was 2.274 ± 0.250,the activity of luciferase in group NC was 2.202 ± 0.073.The luciferase activity of the wild type 3'untranslated regions (3'UTR) of the reporter gene vector was significantly lower than that of the negative control group and the blank control group (The P values of CCLP1 cell line and QBC939 cell line were 0.000,0.000).While there was no significant change in the mutation type.Conclusion MiR-218 inhibits the invasion of cholangiocarcinoma cells and plays a negative regulatory role in the development of cholangiocarcinoma.miR-218 can interact with Survivin 3'UTR directly.Thus miR-218 can have a negative regulatory effect on cholangiocarcinoma through the Survivin directly.

MicroRNA-218 Regulates the Chemo-Sensitivity of Cervical Cancer Cells Through Targeting Survivin.

MicroRNA-218 Enhances the Radiosensitivity of Human Cervical Cancer Via Promoting Radiation Induced Apoptosis.

MicroRNA-708 Suppresses Cell Proliferation and Enhances Chemosensitivity of Cervical Cancer Cells to cDDP by Negatively Targeting Timeless

miR-34b-3p-mediated regulation of STC2 and FN1 enhances chemosensitivity and inhibits proliferation in cervical cancer

MicroRNA-218 Regulates Cisplatin (DPP) Chemosensitivity in Non-Small Cell Lung Cancer by Targeting RUNX2

The Role of miRNAs in Cisplatin-Resistant HeLa Cells.

Suppressed Mir-424 Expression Via Upregulation of Target Gene Chk1 Contributes to the Progression of Cervical Cancer

MicroRNA-181a Enhances the Chemoresistance of Human Cervical Squamous Cell Carcinoma to Cisplatin by Targeting PRKCD.

Targeted Inhibition of miR-221/222 Promotes Cell Sensitivity to Cisplatin in Triple-Negative Breast Cancer MDA-MB-231 Cells.

MicroRNA-218 Promotes Cisplatin Resistance in Oral Cancer Via the PPP2R5A/Wnt Signaling Pathway

Microrna-203 Is A Prognostic Indicator In Bladder Cancer And Enhances Chemosensitivity To Cisplatin Via Apoptosis By Targeting Bcl-W And Survivin

MicroRNA-218 is Upregulated in Gastric Cancer after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy and Increases Chemosensitivity to Cisplatin

MicroRNAs Contribute to the Chemoresistance of Cisplatin in Tongue Squamous Cell Carcinoma Lines.

Influence of survivin gene repression by RNA interference on apoptosis and chemosensitivity of cervical cancer cell line Hela cells

The Pathway Analysis of Micrornas Regulated Drug-Resistant Responses in HeLa Cells.

Study on the Correlation of the Effect of Microrna-218 Through Survivin on Cholangiocarcinoma Cells

MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway

MicroRNA-138 Inhibits Tumor Growth and Enhances Chemosensitivity in Human Cervical Cancer by Targeting H2AX

MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine

Microrna-146a-5p Enhances Cisplatin-Induced Apoptosis in Ovarian Cancer Cells by Targeting Multiple Anti-Apoptotic Genes

MicroRNA 192 Regulates Chemo-Resistance of Lung Adenocarcinoma for Gemcitabine and Cisplatin Combined Therapy by Targeting Bcl-2.